Erez Eitan

Erez Eitan is an accomplished and innovative researcher with a strong background in neurodegenerative diseases therapeutics and diagnosis.

Eitan has a remarkable ability to synthesize vast amounts of data and lead collaborative research projects, resulting in over 25 published articles in peer-reviewed journals.

His dedication to advancing precision medicine is evident through his development of a groundbreaking exosomes sorting platform for Alzheimer's disease detection and tumor tissue gene expression signature recapitulation via a blood test.

Eitan excels in experimental design, exosomes isolation, immune assays, diagnostic assay validation, cell culture, and animal models.

His educational background includes a PhD in Molecular Neuroscience, a Master of Business Administration in Entrepreneurship, and a Bachelor of Science in Life Science, all achieved with Magna Cum Laude honors.

Professionally, Eitan serves as the Chief Scientific Officer at NeuroDex and has held significant roles at Exosome Diagnostics, the National Institutes of Health (NIH-NIA), and as a Lecturer at Ben-Gurion University.